Taiji Furukawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Taiji Furukawa has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Takaaki Isshiki
Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173, Japan
5 shared publicationsToshihide Nukada
3 shared publications- Masaaki Suzuki
Department of Otorhinolaryngology, Teikyo University Chiba Medical Center, Chiba, Japan
2 shared publications Reiko Miura
From the *Department of Medicine, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan; and †Department of Neuronal Signaling, Tokyo Institute of Psychiatry, Setagaya-ku, Tokyo, Japan
2 shared publicationsAkira Yamashina
Department of Cardiology, Tokyo Medical University, Tokyo, Japan
1 shared publicationAkiyo Nakano
Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan
1 shared publication
Latest Publications
- 17 February 2022
- Published by Elsevier in Auris Nasus Larynx
- Vol. 49 (5) , 805-809
Preoperative apnea-hypopnea index predicts increased postoperative intrathoracic pressure during sleep in patients who underwent endoscopic nasal surgery
- 17 February 2022
- Published by Elsevier in Auris Nasus Larynx
- Vol. 49 (5) , 805-809
Preoperative apnea-hypopnea index predicts increased postoperative intrathoracic pressure during sleep in patients who underwent endoscopic nasal surgery
- 1 December 2021
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 321 (6) , F771-F784
A novel I551F variant of the Na+/HCO3− cotransporter NBCe1-A shows reduced cell surface expression, resulting in diminished transport activity
Homozygous mutations in SLC4A4, encoding the electrogenic Na+/HCO3- cotransporter NBCe1, cause proximal renal tubular acidosis (pRTA) associated with extrarenal symptoms. Although 17 mutated sites in SLC4A4 have thus far been identified among pRTA patients, physiological significance of other nonsynonymous single nucleotide variants (SNVs) remains largely undetermined. Here, we investigated the functional properties of SNVs in NBCe1. From NCBI dbSNP database, we identified 13 SNVs that have not previously been characterized in highly conserved, transmembrane domains of NBCe1-A. Immunocytochemical analysis revealed that I551F variant was present predominantly in the cytoplasm in HEK293 cells, whereas all other SNVs did not show as dramatic a change in subcellular distribution. Western blot analysis in HEK293 cells demonstrated that the I551F variant showed impaired glycosylation and a 69 % reduction in cell surface levels. To determine the role of I551 in more detail, we examined the significance of various artificial mutants both in non-polarized HEK293 cells and polarized MDCK cells, which indicated that only I551F substitution resulted in cytoplasmic retention. Moreover, functional analysis using Xenopus oocytes demonstrated that the I551F variant had a significantly reduced activity corresponding to 39 % of that of wild-type, whereas any other SNVs and artificial I551 mutants did not show significant changes in activity. Finally, immunofluorescence study in HEK293 cells indicated that the I551F variant retains wild-type NBCe1-A in the cytoplasm. These data demonstrate that I551F-NBCe1-A shows impaired transport activity predominantly through cytoplasmic retention, and suggest that the variant can have a dominant-negative effect by forming complexes with wild-type NBCe1-A.
- 1 December 2021
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 321 (6) , F771-F784
A novel I551F variant of the Na+/HCO3− cotransporter NBCe1-A shows reduced cell surface expression, resulting in diminished transport activity
Homozygous mutations in SLC4A4, encoding the electrogenic Na+/HCO3- cotransporter NBCe1, cause proximal renal tubular acidosis (pRTA) associated with extrarenal symptoms. Although 17 mutated sites in SLC4A4 have thus far been identified among pRTA patients, physiological significance of other nonsynonymous single nucleotide variants (SNVs) remains largely undetermined. Here, we investigated the functional properties of SNVs in NBCe1. From NCBI dbSNP database, we identified 13 SNVs that have not previously been characterized in highly conserved, transmembrane domains of NBCe1-A. Immunocytochemical analysis revealed that I551F variant was present predominantly in the cytoplasm in HEK293 cells, whereas all other SNVs did not show as dramatic a change in subcellular distribution. Western blot analysis in HEK293 cells demonstrated that the I551F variant showed impaired glycosylation and a 69 % reduction in cell surface levels. To determine the role of I551 in more detail, we examined the significance of various artificial mutants both in non-polarized HEK293 cells and polarized MDCK cells, which indicated that only I551F substitution resulted in cytoplasmic retention. Moreover, functional analysis using Xenopus oocytes demonstrated that the I551F variant had a significantly reduced activity corresponding to 39 % of that of wild-type, whereas any other SNVs and artificial I551 mutants did not show significant changes in activity. Finally, immunofluorescence study in HEK293 cells indicated that the I551F variant retains wild-type NBCe1-A in the cytoplasm. These data demonstrate that I551F-NBCe1-A shows impaired transport activity predominantly through cytoplasmic retention, and suggest that the variant can have a dominant-negative effect by forming complexes with wild-type NBCe1-A.
- Open Access
- 18 November 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (11) , 1816
Emergence of Enterobacter cloacae Complex Co-Producing IMP-10 and CTX-M, and Klebsiella pneumoniae Producing VIM-1 in Clinical Isolates in Japan
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan. Methods: Carbapenem-resistant clinical isolates were collected in 2018 at Teikyo University Hospital (Tokyo, Japan). Bacterial species were identified using MALDI-TOF MS. Carbapenemase production was evaluated using a carbapenemase inactivation method. The presence of carbapenemase genes was confirmed by multiplex PCR and DNA sequencing. Results: Four CPE isolates were identified: two Enterobacter cloacae complex strains and Klebsiella oxytoca and Klebsiella pneumoniae strains. Three of the isolates (E. cloacae complex and K. oxytoca) were IMP-1-type producers, including IMP-10 in their produced metallo-β-lactamase, and are epidemic in East Japan. The IMP-10-producing E. cloacae complex strain also produced CTX-M ESBL. The other CPE isolate (K. pneumoniae) is a VIM-1 producer. VIM-1-producing K. pneumoniae is epidemic in Europe, especially in Greece. Accordingly, the VIM-1 producer was isolated from a patient with a medical history in Greece. Conclusions: This study revealed the emergence of E. cloacae complex co-producing IMP-1-type carbapenemase and CTX-M ESBL, and K. pneumoniae producing VIM-1 carbapenemase in clinical isolates in Japan. Metallo-β-lactamase was the most prevalent type of carbapenemase at Teikyo University Hospital, especially IMP-1-type carbapenemase. The detection of VIM-1-producing K. pneumoniae suggests that epidemic CPE from overseas can spread to countries with low CPE prevalence, such as Japan, highlighting the need for active surveillance.
- 18 November 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (11) , 1816
Open AccessEmergence of Enterobacter cloacae Complex Co-Producing IMP-10 and CTX-M, and Klebsiella pneumoniae Producing VIM-1 in Clinical Isolates in Japan
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan. Methods: Carbapenem-resistant clinical isolates were collected in 2018 at Teikyo University Hospital (Tokyo, Japan). Bacterial species were identified using MALDI-TOF MS. Carbapenemase production was evaluated using a carbapenemase inactivation method. The presence of carbapenemase genes was confirmed by multiplex PCR and DNA sequencing. Results: Four CPE isolates were identified: two Enterobacter cloacae complex strains and Klebsiella oxytoca and Klebsiella pneumoniae strains. Three of the isolates (E. cloacae complex and K. oxytoca) were IMP-1-type producers, including IMP-10 in their produced metallo-β-lactamase, and are epidemic in East Japan. The IMP-10-producing E. cloacae complex strain also produced CTX-M ESBL. The other CPE isolate (K. pneumoniae) is a VIM-1 producer. VIM-1-producing K. pneumoniae is epidemic in Europe, especially in Greece. Accordingly, the VIM-1 producer was isolated from a patient with a medical history in Greece. Conclusions: This study revealed the emergence of E. cloacae complex co-producing IMP-1-type carbapenemase and CTX-M ESBL, and K. pneumoniae producing VIM-1 carbapenemase in clinical isolates in Japan. Metallo-β-lactamase was the most prevalent type of carbapenemase at Teikyo University Hospital, especially IMP-1-type carbapenemase. The detection of VIM-1-producing K. pneumoniae suggests that epidemic CPE from overseas can spread to countries with low CPE prevalence, such as Japan, highlighting the need for active surveillance.
- Open Access
Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of Proteus mirabilis in Japan
- 1 December 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 272, 308-313
Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension
- 1 December 2018
- Published by Elsevier in International Journal of Cardiology
- Vol. 272, 308-313
Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension
- 1 April 2014
- Published by Bentham Science Publishers Ltd. in Current Hypertension Reviews
- Vol. 9 (3) , 170-181
Types of Voltage-Gated Calcium Channels: Molecular and Electrophysiological Views
Voltage-gated calcium (Ca2+) channels are ubiquitous in excitable cells, and intracellular Ca2+ transients, in which the channels play key roles, trigger many physiological events. At this time, 10 members of the voltage-gated Ca2+ channel family in mammals are recognized, and they play diverse roles in the signal transduction system. The CaV1 subfamily (L-type) is involved in contraction, secretion, integration of synaptic input in neurons, regulation of gene expression, and, in specialized sensory cells, synaptic transmission at ribbon synapses. The members of the CaV2 subfamily (P/Q-, N-, and R-types) initiate synaptic transmission at fast synapses. The CaV3 subfamily is important in rhythmically firing cells such as cardiac nodal cells and thalamic neurons. The channels in this family are essential for the cyclic firing of action potentials. This article summarizes the relationships between the molecular and physiological functions of these Ca2+ channel proteins.
- 1 April 2014
- Published by Bentham Science Publishers Ltd. in Current Hypertension Reviews
- Vol. 9 (3) , 170-181
Types of Voltage-Gated Calcium Channels: Molecular and Electrophysiological Views
Voltage-gated calcium (Ca2+) channels are ubiquitous in excitable cells, and intracellular Ca2+ transients, in which the channels play key roles, trigger many physiological events. At this time, 10 members of the voltage-gated Ca2+ channel family in mammals are recognized, and they play diverse roles in the signal transduction system. The CaV1 subfamily (L-type) is involved in contraction, secretion, integration of synaptic input in neurons, regulation of gene expression, and, in specialized sensory cells, synaptic transmission at ribbon synapses. The members of the CaV2 subfamily (P/Q-, N-, and R-types) initiate synaptic transmission at fast synapses. The CaV3 subfamily is important in rhythmically firing cells such as cardiac nodal cells and thalamic neurons. The channels in this family are essential for the cyclic firing of action potentials. This article summarizes the relationships between the molecular and physiological functions of these Ca2+ channel proteins.
- 22 October 2013
- Published by Elsevier in Journal of Cardiology
- Vol. 63 (4) , 281-285
Long-term adherence to nasal continuous positive airway pressure therapy by hypertensive patients with preexisting sleep apnea
- 22 October 2013
- Published by Elsevier in Journal of Cardiology
- Vol. 63 (4) , 281-285
Long-term adherence to nasal continuous positive airway pressure therapy by hypertensive patients with preexisting sleep apnea
- 1 June 2009
- Published by Elsevier in European Journal of Pharmacology
- Vol. 613 (1-3) , 100-107
Five different profiles of dihydropyridines in blocking T-type Ca2+ channel subtypes (Cav3.1 (α1G), Cav3.2 (α1H), and Cav3.3 (α1I)) expressed in Xenopus oocytes
- 1 June 2009
- Published by Elsevier in European Journal of Pharmacology
- Vol. 613 (1-3) , 100-107
Five different profiles of dihydropyridines in blocking T-type Ca2+ channel subtypes (Cav3.1 (α1G), Cav3.2 (α1H), and Cav3.3 (α1I)) expressed in Xenopus oocytes
- 28 February 2009
- Published by Elsevier in Journal of Cardiology
- Vol. 53 (1) , 79-85
Screening method for severe sleep-disordered breathing in hypertensive patients without daytime sleepiness
- 28 February 2009
- Published by Elsevier in Journal of Cardiology
- Vol. 53 (1) , 79-85
Screening method for severe sleep-disordered breathing in hypertensive patients without daytime sleepiness
- 1 July 2006
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (6) , 1823-1824
FK506 Induces the Atrophy of Enteric Ganglia in Small Bowel Transplantation, Which Can Be Prevented by the Neuropeptide Bombesin
- 1 July 2006
- Published by Elsevier in Transplantation Proceedings
- Vol. 38 (6) , 1823-1824
FK506 Induces the Atrophy of Enteric Ganglia in Small Bowel Transplantation, Which Can Be Prevented by the Neuropeptide Bombesin